NTRA Company Profile and Key Details
NASDAQ : NTRA
Natera
$207.98
4.77+2.35%
Open: 4:00 PM56.78
B-ESG ScoreESG Rating
Price Chart
Stock Price Today
Natera, Inc. (NTRA) stock surged +2.35%, trading at $207.98 on NASDAQ, up from the previous close of $203.21. The stock opened at $200.16, fluctuating between $198.64 and $210.99 in the recent session.
Stock Snapshot
203.21
Prev. Close
29.48B
Market Cap
198.64
Day Low
-136.83
P/E Ratio
-1.52
EPS (TTM)
-2.4
Cash Flow per Share
200.16
Open
141.73M
Number of Shares
210.99
Day High
92.43%
Free Float in %
6.42
Book Value
1.28M
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 02, 2026 | 198.19 | 210.99 | 198.02 | 207.98 | 1.28M |
| Apr 01, 2026 | 201.00 | 205.98 | 199.66 | 203.21 | 1.29M |
| Mar 31, 2026 | 190.34 | 200.56 | 190.29 | 199.99 | 1.42M |
| Mar 30, 2026 | 184.03 | 187.00 | 181.48 | 186.84 | 994.95K |
| Mar 27, 2026 | 195.69 | 195.99 | 181.00 | 182.65 | 1.06M |
| Mar 25, 2026 | 196.40 | 202.88 | 195.79 | 197.37 | 665.47K |
| Mar 24, 2026 | 198.77 | 198.77 | 191.50 | 194.52 | 764.45K |
| Mar 23, 2026 | 197.10 | 201.87 | 196.74 | 200.09 | 853.33K |
| Mar 20, 2026 | 200.63 | 201.29 | 194.02 | 195.28 | 2.36M |
| Mar 19, 2026 | 196.63 | 204.34 | 196.00 | 202.73 | 1.22M |
| Mar 18, 2026 | 197.54 | 200.43 | 195.29 | 197.79 | 1.39M |
| Mar 17, 2026 | 199.53 | 203.29 | 197.75 | 198.38 | 1.14M |
| Mar 16, 2026 | 191.44 | 198.18 | 190.67 | 197.68 | 1.56M |
| Mar 13, 2026 | 191.38 | 192.36 | 187.01 | 187.85 | 1.26M |
| Mar 12, 2026 | 193.75 | 195.40 | 186.07 | 190.31 | 1.76M |
| Mar 11, 2026 | 196.36 | 201.27 | 194.55 | 196.61 | 1.4M |
| Mar 10, 2026 | 205.98 | 207.08 | 198.45 | 198.95 | 815.07K |
| Mar 09, 2026 | 194.19 | 205.62 | 194.19 | 205.22 | 1.42M |
| Mar 06, 2026 | 193.27 | 198.34 | 193.27 | 198.13 | 1.19M |
| Mar 03, 2026 | 195.67 | 210.51 | 192.60 | 207.04 | 1.54M |
Contact Details
About Company
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.
Company Information
| Employees | 4424 |
| Beta | 1.7 |
| Sales or Revenue | $1.08B |
| 5Y Sales Change% | 1.109% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
Stock Peers
IDXX
4.89+0.87%
IDEXX Laboratories, Inc.$569.55MEDP8.86+1.81%
Medpace Holdings, Inc.$498.34ILMN0.75+0.59%
Illumina, Inc.$127.38ICLR2.77+2.49%
ICON Public Limited Company$114.19EXAS00
Exact Sciences Corporation$104.91GH2.68+2.94%
Guardant Health, Inc.$93.83BLLN-3.6-4.34%
BillionToOne, Inc.$79.36GRAL1.39+2.59%
GRAIL, Inc.$54.99RDNT-0.52-0.94%
RadNet, Inc.$54.79TWST0.67+1.35%
Twist Bioscience Corporation$50.21Company Overview
Natera, Inc. (NASDAQ:NTRA) closed at $207.98 USD, gaining $4.77 (2.35%) from the previous close of $203.21. The stock is currently mid-range between its 52-week high and low $125.38 and $256.36. With a market capitalization of about $29.48 billion, Natera, Inc. is classified as a large-cap and shows higher-than-market volatility (beta ~1.70). Key stats such as the average daily volume over the past year has been around 1.21 million shares, in line with its 52-week average. Headquartered in Austin, CA, Natera, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Steven Leonard Chapman, the company employs approximately 4,424 people and listed since July 01, 2015. Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide.
Technical Performance
Short-term trend indicators are mixed aligned (SMA20 1.03%, SMA50 -4.83%, SMA200 15.08%). The stock’s 14-day RSI is 47.9 (neutral), while the ATR of 8.08 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -15.7% below its high and over 72.36% above its low. Average 10-day trading volume of 1.07 million shares is below the 3-month average of 1.20 million, indicating normal recent market interest.
Valuation Metrics
Natera, Inc. trades at a P/E ratio of -137.37, slightly below the S&P 500 average, with a price-to-sales ratio of 12.85 and a price-to-book ratio of 16.7 reflecting a rich premium to book value. The P/FCF stands at 306.82, also above market averages. Compared to sector medians, Natera, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.
Dividend & Fair Value
Natera, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$179.21. This means the shares are trading below this model’s fair value.
Earnings & Analyst Outlook
Natera, Inc. generated EPS of -$2.28 over the past year. Five-year average earnings growth is 3.18%. Wall Street analysts project EPS growth of 46.31% annually over the next five years. The latest quarter delivered EPS of -$0.64. The next quarter is forecast at -$0.51. Next year's EPS is expected at $31.15. Analyst sentiment is bullish. Analyst rating data shows there are 19 Strong Buy ratings, 11 Buy ratings, 4 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $300.00 to $160.00. The high target offers 44.24% upside. The low target suggests -23.07% downside. The mean target is $234.35. This offers 12.68% upside. Natera, Inc. earnings surprise history is a mixed track record. The quarter that ended November 06, 2025, missed forecasts by 64.1%. The prior quarter beat by 23.33%. Over the last six quarters, Apple has recorded several small beats. These include -56.52% in August 08, 2024.
Shareholding & Insider Activity
Natera, Inc. has 137.25 million shares outstanding. The public float is 132.85 million shares, elevated short interest at 3.17% of float. This equals 4.17 million shares. The short ratio is 2.51 days. Institutional investors hold 99.53% of the float. Insiders own 3.2%. Rabinowitz Matthew holds 2.31 million shares, BOTHA ROELOF has 1.15 million shares and RABINOWITZ DANIEL has 233.28 thousand shares. Over the past six months, insider transactions show net selling. They sold 485.77 thousand shares across 97 transactions.
Financial & Profitability Overview
On valuation metrics, Natera trades at a P/E of -137.37, P/S of 12.85 and P/B of 16.70. The current ratio is 3.39 and quick ratio is 3.24. Operationally, the company’s inventory turnover is 11.84 and cash conversion cycle is 62.82 days. Debt-to-equity is 0.13, supported by a cash flow-to-debt ratio of 1.00.
Quarterly Financial Highlights
The company ended the quarter with $878.98M in cash and short-term investments, a total debt of $441.99M, and net debt of - $200.10M. Total assets were $1.46B, with equity of $765.33M. Financials further reflected weakness, with operating cash flow of - $246.96M, free cash flow of - $286.15M, and capital expenditures of - $39.20M.
Price Forecast & Outlook
Our AI price prediction model suggests that Natera, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -3.91%, with price expected at $199.85 by April 16, 2026, within a range of $194.78 to $205.44 3-Month Outlook: Projected rise of 46.47%, reaching $304.63 by July 01, 2026, with a range of $296.30 to $313.18. 1-Year Outlook: Projected gain of 28.93%, with price at $268.14 by April 02, 2027, within a range of $262.04 to $276.15.
Key Takeaways
Natera, Inc. (NASDAQ:NTRA) shares are flat 2.51% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Natera, Inc. trading at a premium to the broader market with a P/E of -137.37. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $148.65, suggesting -28.53% downside. Our AI forecast model points to short-term weakness (-3.91% over two weeks), a medium-term rise (46.47% over three months), and a longer-term gain (28.93% over one year), with expected trading ranges indicating moderate volatility.
Frequently Asked Questions
What is the current Natera, Inc. (NTRA) stock price?
Natera, Inc. (NASDAQ: NTRA) stock price is $207.98 in the last trading session. During the trading session, NTRA stock reached the peak price of $210.99 while $198.64 was the lowest point it dropped to. The percentage change in NTRA stock occurred in the recent session was 2.35% while the dollar amount for the price change in NTRA stock was $4.77.
NTRA's industry and sector of operation?
The NASDAQ listed NTRA is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Natera, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of NTRA?
Mr. Steven Leonard Chapman
Chief Executive Officer, Pres & Director
Mr. Rishi Kacker
Chief Technology Officer
Mr. Phil Grinnell
Vice President of Sales
Ms. Olesya A. Anisimova CPA
Chief Accounting Officer
Mr. Robert A. Schueren
Chief Operating Officer
Mr. Michael B. Brophy M.B.A.
Chief Financial Officer
Mr. Jonathan Sheena M.Eng.
Co-Founder & Director
Mr. Eric A. Evans
Chief Scientific Officer
Dr. Matthew Rabinowitz Ph.D.
Co-Founder & Executive Chairman
Paul Greenland
Vice President of Corporation Marketing
Mr. Jerry Diffley
Chief Compliance & Privacy Officer
Mr. Daniel Rabinowitz L.L.M., LL.M.
Sec. & Chief Legal Officer
Chief Executive Officer, Pres & Director
Mr. Rishi Kacker
Chief Technology Officer
Mr. Phil Grinnell
Vice President of Sales
Ms. Olesya A. Anisimova CPA
Chief Accounting Officer
Mr. Robert A. Schueren
Chief Operating Officer
Mr. Michael B. Brophy M.B.A.
Chief Financial Officer
Mr. Jonathan Sheena M.Eng.
Co-Founder & Director
Mr. Eric A. Evans
Chief Scientific Officer
Dr. Matthew Rabinowitz Ph.D.
Co-Founder & Executive Chairman
Paul Greenland
Vice President of Corporation Marketing
Mr. Jerry Diffley
Chief Compliance & Privacy Officer
Mr. Daniel Rabinowitz L.L.M., LL.M.
Sec. & Chief Legal Officer
How NTRA did perform over past 52-week?
NTRA's closing price is 65.88% higher than its 52-week low of $125.38 where as its distance from 52-week high of $256.36 is -18.87%.
How many employees does NTRA have?
Number of NTRA employees currently stands at 4,424.
Link for NTRA official website?
Official Website of NTRA is: https://www.natera.com
How do I contact NTRA?
NTRA could be contacted at phone 650 249 9090 and can also be accessed through its website. NTRA operates from 13011 McCallen Pass Building A, Austin, CA 78753, United States.
How many shares of NTRA are traded daily?
NTRA stock volume for the day was 1.28M shares. The average number of NTRA shares traded daily for last 3 months was 1.21M.
What is the market cap of NTRA currently?
The market value of NTRA currently stands at $29.48B with its latest stock price at $207.98 and 141.73M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep